Evidence map›Paper›PMID 37231308›Full record

ReviewEuropean journal of clinical pharmacology2023

Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review.

Khadija Mansour, Zohra Chadli, Ichrak Ghachem, Nadia Ben Fredj, Haifa Ben Romdhane, Najah Ben Fadhel, Naceurs Boughatas, Karim Aouam, Amel Chaabane, Samia Younes

Open access · bronzeAbstract readReview
In one paragraph

Review in European journal of clinical pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Khadija MansourDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia. khadija.mansour2@gmail.com.
Zohra ChadliDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia.
Ichrak GhachemDepartment of Neurology, Taher Sfar University Hospital, Mahdia, Tunisia.
Nadia Ben FredjDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia.
Haifa Ben RomdhaneDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia.
Najah Ben FadhelDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia.
Naceurs BoughatasDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia.
Karim AouamDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia.
Amel ChaabaneDepartment of Pharmacology, Fattouma Bourguiba University Hospital of Monastir, Monastir, Tunisia.
Samia YounesDepartment of Neurology, Taher Sfar University Hospital, Mahdia, Tunisia.
Hospital Fatuma Bourguiba Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAutoimmune encephalitis is a neurological emergency of new-onset altered mental status, caused by an exaggerated immune-mediated response that targets the central nervous system. Autoimmune encephalitis has become an emerging differential diagnosis, when a classical infection cannot explain neurological symptoms. Displaying overlapping clinical presentations, ranging from the insidious onset of cognitive deficiency to more severe forms of encephalopathy with refractory seizures, autoimmune encephalitis can be challenging for clinicians. When evidence of malignancy is absent and pathogenic autoantibodies are undetected, with typical clinical and imaging features of autoimmune encephalitis, seronegative autoimmune encephalitis may be considered. Recently, vaccination-related autoimmune encephalitis and acute encephalitis after COVID-19 vaccination have attracted attention. METHODS AND

resultsWe report a case series consisting of three patients with autoimmune encephalitis occurring shortly after COVID-19 vaccination and a current review of all previous reported autoimmune encephalitis related to COVID-19 vaccines.

conclusionWe emphasise on the prompt diagnosis of autoimmune encephalitis induced by Covid-19 vaccines and its timely treatment to improve the clinical outcome of this severe neurological condition. Post-licencing vaccine safety surveillance for potential adverse events is essential for vaccine safety and public confidence.

Indexed as

Autoimmune Diseases of the Nervous SystemCOVID-19EncephalitisCOVID-19 TestingCOVID-19 VaccinesHashimoto DiseaseHumansCOVID-19 VaccinesAdverse drug reactionAutoimmune encephalitisCOVID-19 vaccinesNeuroinflammationNeurological complications

Identifiers

PMID37231308
PMCPMC10212735
OpenAlexW4378188922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.